PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY OF VERINURAD (RDEA3170), A SELECTIVE URIC ACID REABSORPTION INHIBITOR, IN HEALTHY ADULT MALE SUBJECTS

被引：0
|
作者：
Gillen, M. [1 ]
Shen, Z. [2 ]
Miner, J. N. [2 ]
机构：
[1] AstraZeneca, Gaithersburg, MD USA
[2] Ardea Biosci Inc, San Diego, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.5133
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0886
引用
收藏
页码：1366 / 1366
页数：1
相关论文
共 50 条
  • [31] The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects
    Liu, Yue
    Chen, Wei
    He, Xuemei
    He, Anshun
    Zhao, Liyuan
    Xie, Tian
    Li, Yue
    Zhao, Jing
    Hunt, Allen
    Shi, Aixin
    Gan, Zhong-Ru
    DIABETES OBESITY & METABOLISM, 2025,
  • [32] CNS Occupancy, Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of JNJ-42165279, a Potent and Selective Inhibitor of Fatty Acid Amide Hydrolase (FAAH) in Healthy Subjects
    Schmidt, Mark E.
    Pemberton, Darrel J.
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 207S - 207S
  • [33] The Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, and Tolerability of JNJ-42165279, a Potent and Selective Inhibitor of Fatty Acid Amide Hydrolase (FAAH) in Healthy Subjects
    Zannikos, Peter
    Wennerholm, Michelle
    Van Der Ark, Peter
    Vaccaro, Nicole
    Schmidt, Mark
    Rassnick, Stefanie
    Pemberton, Darrel
    Palmer, James
    Bredt, David
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S453 - S454
  • [34] Pharmacodynamics and Pharmacokinetics of DRL-17822, a Potent CETP Inhibitor, in Healthy Male Subjects
    Hasham, Sumera N.
    Mangapathiraju, Tippana
    Vittal, Shivva
    Bapat, Abhijit
    Rao, Mallikarjuna
    Sai, Sesha
    Shanavas, Alikunju
    Allenby, Kent
    Kumar, Rajinder
    DIABETES, 2010, 59 : A173 - A173
  • [35] Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium-competitive acid blocker, in healthy male subjects
    Sunwoo, J.
    Oh, J.
    Moon, S. J.
    Ji, S. C.
    Lee, S. H.
    Yu, K. -S.
    Kim, H. S.
    Lee, A.
    Jang, I. -J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (02) : 206 - 218
  • [36] SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), AND PHARMACODYNAMICS (PD) OF SINGLE DOSES OF TAK-272, A NOVEL RENIN INHIBITOR, IN HEALTHY MALE SUBJECTS
    Matsuno, K.
    Kuroda, S.
    Tanaka, S.
    Nakamichi, H.
    Komura, E.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [37] Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects
    Shin, Dongseong
    Lee, SeungHwan
    Yi, Sojeong
    Yoon, Seo Hyun
    Cho, Joo-Youn
    Bahng, Mi Young
    Jang, In-Jin
    Yu, Kyung-Sang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 713 - 723
  • [38] Safety, tolerability, pharmacokinetics and pharmacodynamics of irbesartan after single and multiple doses in healthy male subjects.
    Marino, MR
    Langenbacher, KM
    Ford, NF
    Uderman, HD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII53 - PII53
  • [39] THE SAFETY, TOLERABILITY, PHARMACODYNAMICS, AND PHARMACOKINETICS OF ORAL TAK-994 IN SLEEP DEPRIVED HEALTHY MALE SUBJECTS
    Olsson, T.
    Padmanabhan, J.
    Neuwirth, R.
    Faessel, H.
    Hang, Y.
    Naylor, M.
    SLEEP MEDICINE, 2024, 115 : 227 - 228
  • [40] PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF DWP14012, A NOVEL ACID PUMP ANTAGONIST, IN HEALTHY SUBJECTS
    Oh, Jaeseong
    Lee, SeungHwan
    Moon, Seol Ju
    Lee, Seung-Chul
    Lee, Areum
    Jang, In-Jin
    GASTROENTEROLOGY, 2017, 152 (05) : S464 - S464
12345